Evidence map›Paper›PMID 37915329›Full record

ArticleFrontiers in medicine2023

Specific neuropsychiatric symptoms are associated with functional decline trajectories in Alzheimer's disease and Lewy body dementia: a five-year follow-up study.

Miguel Germán Borda, Kolbjørn Kallesten Brønnick, Elkin Garcia-Cifuentes, Alberto Jaramillo-Jimenez, Carlos Reyes-Ortiz, Jonathan Patricio-Baldera, Hogne Soennesyn, Mario Ulises Pérez-Zepeda, Audun Osland Vik-Mo, Dag Aarsland

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. The prevalence of apathy in Lewy body dementia: A systematic review and meta-analysis.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Pooled it
  2. Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  3. Behavioral disorders in dementia with Lewy bodies: old and new knowledge.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
  4. Lewy Body Dementia.Continuum (Minneapolis, Minn.) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 7 countries.

Miguel Germán BordaCentre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.
Kolbjørn Kallesten BrønnickCentre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.
Elkin Garcia-CifuentesSemillero de Neurociencias y Envejecimiento, Ageing Institute, Medical School, Pontificia Universidad Javeriana, Bogotá, Colombia.
Alberto Jaramillo-JimenezCentre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.
Carlos Reyes-OrtizInstitute of Public Health, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, United States.
Jonathan Patricio-BalderaCentre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.
Hogne SoennesynCentre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.
Mario Ulises Pérez-ZepedaInstituto Nacional de Geriatría, Dirección de Investigación, Mexico City, Mexico.
Audun Osland Vik-MoCentre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.
Dag AarslandCentre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.
Stavanger University Hospital · NOUniversity of Stavanger · NOFlorida Agricultural and Mechanical University · USInstituto Nacional de Pediatria · MXKarolinska Institutet · SEKing's College London · GBPontificia Universidad Javeriana · COUniversity of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Neuropsychiatric symptoms (NPS) are often overlooked and under-identified symptoms associated with dementia, despite their significant impact on the prognosis of individuals living with the disease. The specific role of certain NPS in functional prognosis remains unclear. Aims: To determine the association of different NPS with functional decline in people living with Alzheimer's disease (AD) or Lewy body dementia (LBD). Methods: This is an analysis of data from the Dementia Study of Western Norway (DemVest) with 196 patients included of which 111 had AD and 85 LBD. The Neuropsychiatric Inventory (NPI) and the Rapid Disability Rating Scale (RDRS-2) for activities of daily living were administered annually for 5 years. NPI total score and individual items with RDRS-2 trajectories were analyzed with linear mixed models. Results: The LBD group exhibited higher levels of functional impairment and a greater burden of NPS at baseline. Over the 5-year follow-up, hallucinations, aggression, depression, anxiety, apathy, disinhibition, aberrant motor behavior, nighttime behavior disturbances, and abnormal eating patterns were significantly associated with the decline in functional abilities in individuals with AD, as well as irritability and aberrant motor behavior in those with LBD. Discussion: These results highlight the relevance of early detection and intervention of these particularly relevant NPS, due to its potential of also impacting physical function. Better detection and management of these NPS could improve functional prognosis in people living with dementia. Conclusion: Specific NPS demonstrate relevant distinct associations with Longitudinal trajectories of functional decline in AD and LBD.

Indexed as

Alzheimer’s diseasebehavioral disturbancesdementiafunctionalityLewy body dementianeuropsychiatric symptoms

Identifiers

PMID37915329
PMCPMC10616879
OpenAlexW4387704765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.